News

Spherix has received its first full-scale production batch of cGMP (FDA Current Good Manufacturing Practice) D-tagatose, USP grade. Spherix will use the tagatose in the process of satisfying

Osiris has reported six-month interim data from phase-II clinical trial, evaluating Prochymal for the treatment of chronic obstructive pulmonary disease (COPD). In the placebo-controlled study, 62 patients were

Covance has initiated integrated radiolabeled clinical pharmacology studies, in compliance with FDA guidance on Metabolites in Safety Testing (MIST). Recent MIST guidance requires earlier human absorption, metabolism and

Phase Forward has launched Empirica Study, formerly the Clinical Trials Signal Detection product (CTSD). The product helps clinical and safety teams to improve their understanding of a product’s

Inaccurate test results may fail to indicate HIV in an infected individual, or indicate HIV when none is present. Under the Medical Devices Regulations, home HIV test kits

Eurand has reported that FDA has extended the June 2009 user fee goal date for the New Drug Application for Zenpep, by three months. Zenpep is a proprietary

BRAHMS, Cezanne, and Lumiphore have signed an agreement to incorporate Lumiphore’s Lumi4 -Tb complexes in BRAHMS diagnostic tests. Lumi4-Tb would increase sensitivity of BRAHMS diagnostic tests and allow

In February 2008, the US District Court for the Central District of California awarded CombiMatrix $31.2 Million in its lawsuit against National Union Fire Insurance Company of Pittsburg,

Biomodels has announced that its customized research program allowed ActoGeniX to get FDA approval for phase 1b clinical trials of AGO13, in cancer patients with oral mucositis. The